NCT06101420View on ClinicalTrials.gov

Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication

PHASE3CompletedINTERVENTIONAL

Enrollment

232

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions

Helicobacter Pylori Eradication

Interventions

DRUG

Vonoprazan

Venoprazan 20mg twice daily,clarithromycin 500mg twice daily,amoxycillin 1 gm twice daily,esomeprazole 20mg twice daily,levofloxacin 500mg a single tablet daily,doxycicline 100mg a single capsule daily and nitazoxanide 500mg twice daily

Trial Locations (1)

11341

Faculty of Medicine Ain Shams University, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT06101420 - Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication | Biotech Hunter | Biotech Hunter